Industry News
Related Searches:
Filter by:
1381 - 1395 of 2385 results
May 8, 2009
AAIPharma has acquired the Xcelodose 600S capsule filling system, enhancing the company’s preclinical and early phase clinical GMP supply capabilities.
Read More »
May 6, 2009
GlaxoSmithKline has entered into an agreement to divest full commercial rights to Wellbutrin XL in the U.S. to Biovail International Laboratories, for $510 million.
Read More »
May 4, 2009
Althea Technologies, Inc. has opened its new commercial-scale cGMP manufacturing facility in San Diego, CA.
Read More »
May 1, 2009
Lancaster Laboratories has been awarded the 2009 Eli Lilly Global Supplier Award for having a measurable impact on the company’s objectives and priorities.
Read More »
May 1, 2009
Novozymes Biopharma's Recombumin and albucult products are the first to comply with the new excipient monograph standard for recombinant human albumin, published in the U.S. Pharmacopoeia - National Formulary (USP-NF). First
Read More »
April 30, 2009
Amylin Pharmaceuticals and Lilly have agreed to the terms of a joint supply agreement for a pen device for exenatide once-weekly.
Read More »
April 29, 2009
ICON has acquired a 33,000-sq.-ft. Phase I facility in Omaha, NE from the former Qualia Clinical Services, Inc., with a capacity of as many as 100 beds.
Read More »
April 27, 2009
Patheon has signed agreements to commercialize two controlled release products utilizing OROS technology from its Cincinnati facility.
Read More »
April 27, 2009
Novozymes Biopharma has begun construction of a new cGMP facility at its existing site in Tianjin, China, enabling the company to produce Bacillus-based Hyaluronic Acid (bHA), HyaCare, for the bio-medical and pharmaceutical industries.
Read More »
April 21, 2009
Chiltern International Ltd. will acquire Vigiun, a full service CRO located in Sao Paulo, Brazil. Vigiun, established in 1999 by Eduardo Forleo, M.D., and Elisa Halker, BSN, has experience conducting clinical trials in a variety of therapeutic areas, incl
Read More »
April 20, 2009
GlaxoSmithKline and Stiefel Laboratories, Inc. have signed an agreement to create a new specialist dermatology business. Under the terms of the agreement, GSK will acquire Stiefel for $2.9 billion in cash with a potential further $0.3 billion cash payment
Read More »
April 20, 2009
AMRI has completed the relocation of its Bothell, WA research unit into approximately 44,000 sq.-ft. of nearby newly refurbished lab and office space.
Read More »
April 17, 2009
Patheon is expanding its Toronto manufacturing facility, adding 10,000 sq. ft. of GMP space dedicated to the production of oral contraceptives.
Read More »
April 16, 2009
GlaxoSmithKline and Pfizer have entered into an agreement to create a new company focused solely on research, development and commercialization of HIV drugs.
Read More »
April 16, 2009
The Chemical Biological Medical Systems Project Management Office of the U.S. Department of Defense (DoD) has signed a four-year agreement with Cangene Corp. to purchase its Vaccinia Immune Globulin Intravenous (Human) (VIG) for use by U.S. military perso
Read More »
1381 - 1395 of 2385 results
